TY  - GEN
AU  - Seibert,Stephan R
AU  - Schladt,David P
AU  - Wu,Baolin
AU  - Guan,Weihua
AU  - Dorr,Casey
AU  - Remmel,Rory P
AU  - Matas,Arthur J
AU  - Mannon,Roslyn B
AU  - Israni,Ajay K
AU  - Oetting,William S
AU  - Jacobson,Pamala A
TI  - Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients
SN  - 1399-0012
PY  - 2019///1203
KW  - Adolescent
KW  - Adult
KW  - Black or African American
KW  - genetics
KW  - Aged
KW  - Aged, 80 and over
KW  - Cytochrome P-450 CYP3A
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Graft Rejection
KW  - drug therapy
KW  - Graft Survival
KW  - drug effects
KW  - Humans
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Incidence
KW  - Kidney Failure, Chronic
KW  - surgery
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Minnesota
KW  - epidemiology
KW  - Postoperative Complications
KW  - Prognosis
KW  - Prospective Studies
KW  - Risk Factors
KW  - Tacrolimus
KW  - White People
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/ctr.13424
ER  -